Cite
HARVARD Citation
Arsenault, P. et al. (2018). NEO6860, modality-selective TRPV1 antagonist. Pain reports. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Arsenault, P. et al. (2018). NEO6860, modality-selective TRPV1 antagonist. Pain reports. p. . [Online].